Nandita Bose, Ph.D., has more than 18 years of accomplishment and innovation in the immuno-oncology field. She joined HiberCell from Biothera Pharmaceuticals, Inc., where she served as senior vice president of translational immunology. She has extensive experience in translational research involving delineation of immunopharmacodynamic effects in healthy volunteers and cancer patients as part of Phase I/II/III company-sponsored trials and investigator-initiated trials/ compassionate-use studies.

In addition to being adjunct faculty at North Dakota State University, she has held leadership roles in several scientific organizations. As the only industry member of the Education Committee of American Association of Immunologists (AAI), she has chaired committee-sponsored symposia to mentor undergrads and post-doctoral fellows. She is a working member of the Industry Council of Society for Immunotherapy of Cancer (SITC) and has sat on scientific grant review committees for the American Association for Cancer Research (AACR). She is a reviewer for several cancer immunology journals including SITC’s leading journal, Journal for Immunotherapy of Cancer (JITC).

Nandita earned her Ph.D. in biomedical sciences from the University of Georgia and conducted her postdoctoral work in cellular immunology at University of Minnesota and 3M Pharmaceuticals.